New dosing strategy aims to ease hormone therapy side effects for breast cancer patients
NCT ID NCT05754528
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 28 times
Summary
This study tests whether starting hormone therapy every other day for a month before switching to daily dosing helps patients tolerate it better and stay on track. About 240 adults with early-stage hormone-sensitive breast cancer will be randomly assigned to either standard daily dosing or the gradual schedule. The goal is to see if the new approach improves medication adherence and reduces side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The Ottawa Hospital Cancer Centre
Ottawa, Ontario, Canada
-
Thunder Bay Regional Health Sciences Centre
Thunder Bay, Ontario, P7B 6V4, Canada
Conditions
Explore the condition pages connected to this study.